It was the priciest biotech startup sale in North Carolina history. Now five years under Bayer, AskBio advances more AAV gene therapies.
US stock futures down, investors focus on Sify, Boot Barn, Wealthfront, Plus Therapeutics, Solowin; Citigroup expected to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback